308 related articles for article (PubMed ID: 17898809)
1. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
Tao Y; Pinzi V; Bourhis J; Deutsch E
Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.
Ryan PD; Goss PE
Oncologist; 2008 Jan; 13(1):16-24. PubMed ID: 18245009
[TBL] [Abstract][Full Text] [Related]
3. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
Riedemann J; Sohail M; Macaulay VM
Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
[TBL] [Abstract][Full Text] [Related]
4. Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.
Hendrickson AW; Haluska P
Curr Opin Investig Drugs; 2009 Oct; 10(10):1032-40. PubMed ID: 19777391
[TBL] [Abstract][Full Text] [Related]
5. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
Tortora G; Ciardiello F; Gasparini G
Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
[TBL] [Abstract][Full Text] [Related]
6. IGF1R signalling and its inhibition.
Riedemann J; Macaulay VM
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S33-43. PubMed ID: 17259557
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
Ewing GP; Goff LW
Clin Colorectal Cancer; 2010 Oct; 9(4):219-23. PubMed ID: 20920993
[TBL] [Abstract][Full Text] [Related]
8. Targeting insulin-like growth factor 1 receptor in sarcomas.
Scotlandi K; Picci P
Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.
Mitsiades CS; Mitsiades N
Expert Rev Anticancer Ther; 2005 Jun; 5(3):487-99. PubMed ID: 16001956
[TBL] [Abstract][Full Text] [Related]
10. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
Hofmann F; García-Echeverría C
Drug Discov Today; 2005 Aug; 10(15):1041-7. PubMed ID: 16055020
[TBL] [Abstract][Full Text] [Related]
11. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
Surmacz E
Oncogene; 2003 Sep; 22(42):6589-97. PubMed ID: 14528284
[TBL] [Abstract][Full Text] [Related]
12. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
13. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
[TBL] [Abstract][Full Text] [Related]
14. Targeting the IGF1 axis in cancer proliferation.
Bruchim I; Attias Z; Werner H
Expert Opin Ther Targets; 2009 Oct; 13(10):1179-92. PubMed ID: 19663648
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for oncogenic activation of the epidermal growth factor receptor.
Zandi R; Larsen AB; Andersen P; Stockhausen MT; Poulsen HS
Cell Signal; 2007 Oct; 19(10):2013-23. PubMed ID: 17681753
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.
Schlueter PJ; Peng G; Westerfield M; Duan C
Cell Death Differ; 2007 Jun; 14(6):1095-105. PubMed ID: 17332774
[TBL] [Abstract][Full Text] [Related]
17. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
[TBL] [Abstract][Full Text] [Related]
18. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
Tognon CE; Sorensen PH
Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
[TBL] [Abstract][Full Text] [Related]
19. IGF-IR: potential role in antitumor agents.
Guerreiro AS; Boller D; Doepfner KT; Arcaro A
Drug News Perspect; 2006 Jun; 19(5):261-72. PubMed ID: 16941048
[TBL] [Abstract][Full Text] [Related]
20. Novel agents on the horizon for cancer therapy.
Ma WW; Adjei AA
CA Cancer J Clin; 2009; 59(2):111-37. PubMed ID: 19278961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
